Introduction
Perinatal asphyxia is defined by the World Health Organisation (WHO) as "Failure to initiate and sustain breathing at birth." (1) There is a high incidence of AKI among the asphyxiated term infants, (50 -72%). (2, 3) . The presence of perinatal asphyxia and its severity appear to correlate with increasing incidence of AKI. (2, 4) Asphyxia is an important cause of AKI and transient kidney impairment with adverse effects, especially in the five days of birth. (5, 6) The kidney is the most damaged organ in asphyxiated full-term infants. (6) There lacks an internationally acceptable definition of AKI in neonates. Most of the previous investigators have defined AKI in neonates as serum creatinine above 133 µmol/(l. 7, 8) The objective of this study was to determine the prevalence of acute kidney injury using serum creatinine above 133 µmol/l and short term outcomes of moderate to severe perinatal asphyxia-associated acute kidney injury.
Methods
This was a prospective cohort conducted at the KNH NBU over a 6 month period (June 2012 to November 2012). All term neonates with moderate to severe perinatal asphyxia admitted within 24hrs of delivery into the NBU. The 56 consecutive term newborns that satisfied the inclusion criteria were enrolled after written informed consent was obtained from either of the parents having given them clear explanation of the purpose of the study, expected benefits and potential harms. Ethical approval was obtained from the Ethical Review Committee, KNH. Newborns with malformation syndromes and those who died within 3 days of admission were excluded from the study. Maternal and neonatal data was captured using pre-tested questionnaires and forms. Perinatal asphyxia was defined as failure to initiate and sustain breathing at birth (1), clinical evidence of HIE (9) and Apgar score less than 7 at 5 minutes. Gestational age was determined us-ing the Finnström score.(10) Emergency care and resuscitation was a priority to any other procedures. Study details were given to the immediate caregivers. No beneficial treatment was withheld from the study subjects. All information about the patient was treated with the strictest confidence.
The neonate's length, body weight and head circumference were measured on admission. Neonatal body weight and the degree of neurological impairment were determined according to Sarnat classification daily until patient discharge, death or day 7 of life. Serum creatinine values were determined on day 2 and 3 of life by heel sampling of 0.5ml to 1ml into a microtainer. The sample was then centrifuged within 2 hours and analysed using Cobas Integra machine using the compensated Jaffẻ method.
Statistical analysis
Statistical analysis was conducted using statistical products and services solutions (SPSS) software version 17.0. Descriptive data were presented as numbers (percentages) or mean (standard deviation), as appropriate. Characteristics were compared using Fischer's exact test for dichotomous variables and Wilcoxon rank-sum test for continuous variables. Test of associations between the neonatal/ maternal factors and the study outcomes were performed using Chi-square test for categorical variables and comparisons of means and medians was done using student's test and Mann Whitney U test respectively. A p-value of 0.05 was considered statistically significant.
Results
Of the 968 newborns admitted into the KNH NBU during the study period, 60 infants met the inclusion criteria and were analysed as shown in figure 1 . The mean weight was 3373 g (SD=427.3), length 52.3 cm (SD=2.1), clinical gestation 39.4 weeks (SD=0.87) and head circumference 34.8 cm (SD=1.6). The neonates weight ranged from 2620 to 4600 g. Only 9% of the neonates admitted had a severe Apgar score (0-3), while 91% had a moderate Apgar score (4-6). Most of the neonates were delivered in KNH (76%), 24% from other facility but none was delivered at home. Most of the neonates were delivered by the vaginal route (63%), 33% via caesarian section and 4% via vacuum extraction. Only 40% of the neonates were resuscitated at birth and 18% intubated and mechanically ventilated. Majority of the mothers (86%) were married and 53% were primigravidae. Majority of the mothers were employed (77%) versus 23% unemployed. Only 15% of the mothers had a level of education of primary school and below versus 75% who had attained secondary level of education and above. Almost all the mothers (90%) reported having attended antenatal clinic (ANC) visit with 75% having attended ANC more than twice and 15% attending only once.
The degree of perinatal asphyxia was staged using Sarnat and Sarnat staging of Hypoxic Ischaemic Encephalopathy (HIE) on admission. Majority 31(52%) had HIE II, 22 (36%) HIE I and 7 (12%) HIE III. Out of the neonates with AKI, 11.1 % (4/36) of the males were affected versus 12.5 % (3/24) of the females. 7 out of 60 neonates met criteria for AKI on day 3. Translates to a prevalence of 11.7%
AKI was highest in the neonates with HIE 3 (42.9%) on day 3 of life and lowest in the neonates with HIE 1 (4.6%) as per figure 2.
There was no statistically significant association between newborn, maternal characteristics and AKI (table 1 and 2). According to the Acute Kidney Injury Network (AKIN), AKI is an absolute increase in serum creatinine of ≥ 26.4μmol/l (or a percentage increase in serum creati-5.11 Before 48h of life, the serum creatinine reflects that of the mother. 8
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Studies by Jayshree 12, Nouri 14 and Gupta 2 chose the threshold of 90 µmol / l for serum creatinine at 48 hours of life. Studies by Karlowicz 3 Kaur 13 chose the serum creatinine threshold of 133 µmol/l at 48 hours to make a diagnosis of AKI. In our study, the threshold of 133 µmol / l for creatinine at 72 hours of life was chosen in order to increase our possibility of diagnosis as there would be a marked reduction in the maternal creatinine level by then.
There is a high incidence of AKI among the asphyxiated term infants (7 -72%). 2,3 AKI after perinatal asphyxia was noted in 42% of cases for Martin-Ancel 4 , 47% to Gupta 2, 68% for Aggrawal 8 ,70% to Gluckman15, 17.2 % Nouri14 and 33% in our study. Our study noted 11.7% prevalence rate hence lying within the range of most of the studies done. The prevalence rate may have been much higher than the Tunisia study if serum creatinine was sampled at 48 hours and threshold of 90 µmol / l used. The available studies show that the prevalence rates were similar in both resource poor and resource rich areas proving that AKI in perinatal asphyxia is a global problem.
The presence of perinatal asphyxia and its severity appears to correlate with increasing incidence of AKI.2,4 Nouri14 who had two thirds of newborns with AKI had grade II and 1/3 with AKI had grade III. However in his study no renal impairment was observed in newborns with grade I. The difference was not statistically significant (p = 0.13). Gupta 2 however showed that blood urea and serum creatinine were significantly higher in asphyxiated and HIE babies compared to the control group (P < 0.001) and (P < 0.05) respectively hence showing the correlation between AKI and HIE. Kaur13 showed that AKI developed in 1 out of 11 infants (9.1%) with moderate asphyxia and in 12 of 25 (56%) with severe asphyxia. Our study noted a 15 fold nine of at least 50%) over two consecutive days.7 Creatinine in the normal newborn at term by Schwartz is 79 µmol / l at day 1 and drops to 44 µmol / l) at day The cause of death for patients diagnosed with AKI may not be the same as the cause of AKI. The mortality rate depends on other associated conditions, e.g. other organ failure, particularly cardiac failure, HIE and serious infection hence the difficulty in quoting the exact mortality rate secondary to AKI in our study and the previous ones. 
